InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
2
T+90 胜率
100%
T+90 平均收益
+8.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Froimson Mark, 董事. Director active across 1 company, notably Pacira BioSciences, Inc.. In total, 9 filings have been recorded. Split: 1 buy · 2 sells. Total volume traded: €80k. Activity tracked since 9 June 2021. The latest transaction was disclosed on 17 March 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Froimson Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
500 股@ US$21.8111.8% 占其流量Common StockSEC:0001628280-26-019890:0
6,163 股0Common StockSEC:0001396814-25-000085:0
1,400 股@ US$11.5820.9% 占其流量Common StockSEC:0001396814-24-000107:0
标准退出：2024年11月10日 (T+90)
5,230 股0Common StockSEC:0001396814-24-000077:0
1,775 股0Common StockSEC:0001209191-23-038020:0
1,160 股0Common StockSEC:0001209191-22-035218:0
1,000 股@ US$59.370.0053% mcap100.0% 占其流量Common StockSEC:0001209191-22-028275:0
400 股0Common StockSEC:0001209191-21-070553:0
1,066 股0Common StockSEC:0001209191-21-040082:0
9 条申报中的 9 条
About Froimson Mark
Froimson Mark is Administrateur at Pacira BioSciences, Inc. (XNAS). He has 9 filings in total, and across the 9 recent filings available, buys amount to EUR 14824 and sells to EUR 65674, with filings dated from 2021-06-11 to 2026-03-19.
